For decades, aspirin has been the standard preventive treatment for patients with blood vessel disease. After an acute ...
The new P2Y 12 antagonists, prasugrel and ticagrelor, are characterized by more potent antiplatelet effects and reduce recurrent ischemic event rates compared with clopidogrel among acute coronary ...
Sabatine: Clopidogrel is a prodrug and it needs to ... we've done the same analysis in patients treated with prasugrel and found that the 2C19 variant does not impact the pharmacokinetics, the ...
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute ...
After hours: January 17 at 5:29:10 PM EST Loading Chart for OR ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
The acute coronary syndrome market is experiencing significant growth, driven by the increasing prevalence of both acute myocardial infarction (AMI) and unstable angina, an aging global population ...